These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377 [TBL] [Abstract][Full Text] [Related]
8. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels. Abdullah L; Paris D; Luis C; Quadros A; Parrish J; Valdes L; Keegan AP; Mathura V; Crawford F; Mullan M Neurosci Lett; 2007 Nov; 428(2-3):53-8. PubMed ID: 17964720 [TBL] [Abstract][Full Text] [Related]
11. Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels. Fukumoto H; Tennis M; Locascio JJ; Hyman BT; Growdon JH; Irizarry MC Arch Neurol; 2003 Jul; 60(7):958-64. PubMed ID: 12873852 [TBL] [Abstract][Full Text] [Related]
13. Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies. Lee M; Bard F; Johnson-Wood K; Lee C; Hu K; Griffith SG; Black RS; Schenk D; Seubert P Ann Neurol; 2005 Sep; 58(3):430-5. PubMed ID: 16130106 [TBL] [Abstract][Full Text] [Related]
14. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology. Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347 [TBL] [Abstract][Full Text] [Related]
15. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089 [TBL] [Abstract][Full Text] [Related]
16. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype. De Jonghe C; Cras P; Vanderstichele H; Cruts M; Vanderhoeven I; Smouts I; Vanmechelen E; Martin JJ; Hendriks L; Van Broeckhoven C Neurobiol Dis; 1999 Aug; 6(4):280-7. PubMed ID: 10448055 [TBL] [Abstract][Full Text] [Related]
17. Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly. Qiu WQ; Sun X; Selkoe DJ; Mwamburi DM; Huang T; Bhadela R; Bergethon P; Scott TM; Summergrad P; Wang L; Rosenberg I; Folstein M Int J Geriatr Psychiatry; 2007 Jun; 22(6):536-42. PubMed ID: 17096467 [TBL] [Abstract][Full Text] [Related]
18. Development of Abeta terminal end-specific antibodies and sensitive ELISA for Abeta variant. Horikoshi Y; Sakaguchi G; Becker AG; Gray AJ; Duff K; Aisen PS; Yamaguchi H; Maeda M; Kinoshita N; Matsuoka Y Biochem Biophys Res Commun; 2004 Jul; 319(3):733-7. PubMed ID: 15184044 [TBL] [Abstract][Full Text] [Related]